Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled Trial.
Thazhath SS, Marathe CS, Wu T, Chang J, Khoo J, Kuo P, Checklin HL, Bound MJ, Rigda RS, Crouch B, Jones KL, Horowitz M, Rayner CK. Thazhath SS, et al. Diabetes. 2016 Jan;65(1):269-75. doi: 10.2337/db15-0893. Epub 2015 Oct 15. Diabetes. 2016. PMID: 26470783 Clinical Trial.
Glucose absorption in small intestinal diseases.
Thazhath SS, Wu T, Young RL, Horowitz M, Rayner CK. Thazhath SS, et al. Expert Rev Gastroenterol Hepatol. 2014 Mar;8(3):301-12. doi: 10.1586/17474124.2014.887439. Epub 2014 Feb 6. Expert Rev Gastroenterol Hepatol. 2014. PMID: 24502537 Review.
Acute effects of the glucagon-like peptide-1 receptor agonist, exenatide, on blood pressure and heart rate responses to intraduodenal glucose infusion in type 2 diabetes.
Thazhath SS, Marathe CS, Wu T, Chang J, Khoo J, Kuo P, Checklin HL, Bound MJ, Rigda RS, Horowitz M, Jones KL, Rayner CK. Thazhath SS, et al. Diab Vasc Dis Res. 2017 Jan;14(1):59-63. doi: 10.1177/1479164116666761. Epub 2016 Oct 20. Diab Vasc Dis Res. 2017. PMID: 27941058 Free article. Clinical Trial.
Augmented capacity for peripheral serotonin release in human obesity.
Young RL, Lumsden AL, Martin AM, Schober G, Pezos N, Thazhath SS, Isaacs NJ, Cvijanovic N, Sun EWL, Wu T, Rayner CK, Nguyen NQ, Fontgalland D, Rabbitt P, Hollington P, Sposato L, Due SL, Wattchow DA, Liou AP, Jackson VM, Keating DJ. Young RL, et al. Among authors: thazhath ss. Int J Obes (Lond). 2018 Nov;42(11):1880-1889. doi: 10.1038/s41366-018-0047-8. Epub 2018 Mar 1. Int J Obes (Lond). 2018. PMID: 29568107
12 results